| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0009 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.25 | 0.001 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.005 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.096 | 0.005 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.006 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.006 |